Atropine-induced cardioacceleration and myocardial blood flow in subjects with and without coronary artery disease.
D000328:Adult; D000889:Anti-Arrhythmia Agents / Q000009:adverse effects*; D001285:Atropine / Q000009:adverse effects* / Q000627:therapeutic use; D001783:Blood Flow Velocity; D002932:Cineangiography; D002986:Clinical Trials as Topic; D017023:Coronary Angiography; D003326:Coronary Circulation / Q000187:drug effects*; D003327:Coronary Disease / Q000150:complications* / Q000503:physiopathology; D005069:Evaluation Studies as Topic; D006339:Heart Rate / Q000187:drug effects*; D006801:Humans; D008297:Male; D008875:Middle Aged; D011865:Radioisotope Dilution Technique; D012413:Rubidium
D000889:Anti-Arrhythmia Agents; D001285:Atropine; D012413:Rubidium